GlassScriptPhysician profile
Avidah Rudberg
NPI 1639124779
$1,180.39
in general payments reported to CMS, 2019-2025
14 companies · $388 in 2025
The $388 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $388 · 2020: $77.23 · 2021: $124 · 2024: $202 · 2025: $388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $506 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $505.77 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $336.22 | 2019-2024 | Xtandi |
| Janssen Biotech, INC. | $197.69 | 2019-2025 | Erleada |
| Laborie Medical Technologies Corp. | $145.98 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Janssen Scientific Affairs, LLC | $133.51 | 2025 | Erleada, Akeega, Balversa |
| Coloplast Corp | $85.46 | 2025 | |
| Aytu Biopharma, INC. | $69.53 | 2019-2020 | |
| Pfizer INC. | $62.50 | 2019-2020 | |
| Urogen Pharma, INC. | $43.02 | 2025 | |
| Boston Scientific Corporation | $20.11 | 2019 | |
| Tolmar, INC. | $19.94 | 2025 | Jatenzo, Eligard |
| Ge Healthcare | $19.09 | 2019 | |
| Antares Pharma, INC. | $18.42 | 2019 | |
| Endo Pharmaceuticals INC. | $15.76 | 2019 | |
| Merck Sharp & Dohme LLC | $13.16 | 2024 | Bridion |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Avidah Rudberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.